Dyspepsia News and Research

RSS

Indigestion, known as ''upset stomach'' or ''dyspepsia'', meaning hard or difficult digestion, is a medical condition characterized by chronic or recurrent pain in the upper abdomen, upper abdominal fullness and feeling full earlier than expected when eating. It can be accompanied by bloating, belching, nausea, or heartburn.

Study links ultra-processed foods to gut health risks

A review in Nature Reviews Gastroenterology & Hepatology synthesizes evidence on the negative impacts of ultra-processed foods and food additives on gut health, linking them to chronic diseases and alterations in the gut microbiome.

25 Feb 2024

Nutrigenomics paves the way for customized diets in lactose intolerance care

The current evidence on omics tools that allow for developing tailored nutrition strategies for individuals with lactose intolerance (LI).

24 Jan 2024

Migraine linked to increased risk of inflammatory bowel disease in new study

A nationwide cohort study reveals that individuals with migraine have a 1.3-fold higher risk of developing inflammatory bowel disease (IBD), suggesting a significant connection between migraine and IBD.

15 Jan 2024

Exploring the gut-brain link: How diet and nutrient absorption impact digestive disorders

The major disorders of gut-brain interactions (DGBIs).

8 Jan 2024

UK Biobank reveals: Mediterranean diet might be the key to combating 32 chronic diseases!

The association between a healthy dietary pattern and 48 individual chronic diseases among community-dwelling adults.

25 Oct 2023

Oral diabetes and obesity meds danuglipron and orforglipron show promise but have gastrointestinal drawbacks

New orally-administered GLP-1 receptor agonists danuglipron and orforglipron show promise in treating type 2 diabetes and obesity, according to a systematic review. While effective in glycemic control and weight reduction, these drugs come with gastrointestinal side effects that may lead to treatment discontinuation.

17 Oct 2023

Can herbal remedies, spices, and dietary fibers offer effective treatment options for children with irritable bowel syndrome (IBS)?

The positive effects and adverse reactions of spices, dietary fiber, and medicinal herbs for pediatric patients with IBS.

16 Oct 2023

Natural compound in turmeric may be as effective as omeprazole for treating indigestion

A natural compound found in the culinary spice turmeric may be as effective as omeprazole-; a drug used to curb excess stomach acid-; for treating indigestion symptoms, suggests the first study of its kind, published online in the journal BMJ Evidence-Based Medicine.

12 Sep 2023

Certain gut conditions associated with higher risk of Parkinson's disease diagnosis

Certain gut problems, such as constipation, difficulty swallowing, and irritable bowel syndrome (IBS), may be early warning signs of the neurological condition Parkinson's disease, suggests research published online in the journal Gut.

24 Aug 2023

Does COVID-19 increase the risk of future gastrointestinal disorders?

Scientists review existing literature to examine the association between acute COVID-19 and the incidence of gastrointestinal symptoms.

2 Aug 2023

Berry beneficial: Blueberry consumption alleviates abdominal pain in gastrointestinal disorders

Researchers investigate whether blueberry consumption could improve the overall quality of life of individuals with functional gastrointestinal disorders.

24 May 2023

What is the gastrointestinal impact of Long Covid?

Researchers assessed gastrointestinal outcomes associated with COVID-19.

9 Mar 2023

The efficacy of clarithromycin versus levofoxacin-based regimens for H.pylori treatment in naïve patients after the COVID-19 pandemic misuse of antibiotics

Researchers explored the eradication rates of Helicobacter pylori utilizing levofloxacin and clarithromycin-based regimens in patients with prior COVID-19 therapy.

25 Jan 2023

Study finds above-average rates of mortality from gastric cancer in South Florida

South Florida counties have above-average rates of mortality from gastric cancer, according to a new study published in the journal Gastroenterology by investigators at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine.

29 Jun 2022

Clinical risk and protective factors for the presence and persistence of abdominal pain-related disorders of gut-brain interaction

The current study carries forward what is known about the risk of AP-DGBI conferred by various factors such as sex, infectious gastroenteritis, trauma, abuse, stress, psychological factors, somatic symptoms, family history, smoking, and drug abuse.

17 Jun 2022

Fecal microbiota transplant shows durable effect in treating irritable bowel syndrome

A new study discusses the efficacy of fecal transplant in patients with IBS three years after the procedure was performed.

16 Jun 2022

Study confirms accuracy of new generation GastroPanel® test

A clinical validation study conducted at Oulu University Hospital (OUH) has confirmed the high accuracy of BIOHIT Oyj’s new generation GastroPanel® test for the diagnosis of atrophic gastritis (AG) and Helicobacter pylori (Hp) infection in patients referred for gastroscopy.

From BIOHIT HealthCare Ltd 6 May 2022

Weight loss drug Wegovy approved by FDA

The U.S. Food and Drug Administration (FDA) has approved Wegovy (semaglutide) injection (2.4 mg once weekly) as a chronic weight management treatment in obese or overweight adults with a weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol), when used along with calorie restriction and physical activity. Wegovy, is a more potent version of Novo Nordisk's diabetes drug semaglutide.

4 Jun 2021

Rumination syndrome often confused with other gastrointestinal conditions

Patients who regurgitate regularly but without any known cause may have a condition called rumination. Unfortunately, rumination is often confused with other gastrointestinal conditions, which means many patients may not be getting prompt treatment.

18 Mar 2021

Antiacid monotherapy is better than combination therapy in relieving epigastric pain

Antacid monotherapy is more effective in relieving epigastric pain than in combination with lidocaine. That is the conclusion of a study to be published in the September 2020 issue of Academic Emergency Medicine (AEM), a journal of the Society for Academic Emergency Medicine (SAEM).

29 Sep 2020